Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Not all breast cancers’ risk are increased by HRT

24.03.2006


Recent research presented today at EBCC-5 from the million women study found that taking Hormone Replacement Therapy (HRT) increased the risk of some types of breast cancer, but not others.



Scientists analysed the data from the UK study to try and find a link between HRT and the type of breast cancer that developed. The research found that women who took HRT had an increased risk of developing lobular cancer (affecting the cells in the ducts of the milk-producing glands) and tubular cancer. There was not such an increased risk of developing ductal breast cancer, the most common type of breast cancer that affects the cells lining the milk duct. There was no increase in the risk of medullary breast cancer, a kind of cancer that is common in women with a genetic predisposition to breast cancer.

The study demonstrated that women who had taken combined HRT (oestrogen and progesterone) had an even greater risk of developing lobular and tubular breast cancer than women on oestrogen only HRT. The researchers also discovered similar findings for women with breast cancer in situ - when the cancer has not spread to the surrounding tissues in the breast or other parts of the body. Women that took HRT had a significantly greater risk of developing lobular cancer in situ than ductal carcinoma in situ.


G. Reeves who presented the findings comments, "It is very interesting that HRT has different effects on different types of breast cancer. One possible explanation for the findings is that certain types of breast cancer are more likely than others to be hormone receptive. Further research into this topic could greatly help our understanding of the biological mechanisms underlying the development of breast cancer."

In 2003, the million women study confirmed that post-menopausal women taking combination HRT were twice as likely as non-users to develop breast cancer and women taking oestrogen-only HRT had a 30 per cent greater risk than those who haven’t taken HRT.

The increase in breast cancer risk starts within one to two years of beginning either form of HRT and increases the longer it is taken. As soon as HRT is stopped, the risk begins to fall and, after five years, is the same as for women who’ve never taken the drug. Combined oestrogen-progesterone HRT is usually prescribed for women who still have a uterus to avoid the increased risk of cancer of the uterus caused by oestrogen-only therapy. Women are advised to discuss their concerns with their doctor.

EBCC-5 Press Office | alfa
Further information:
http://www.fecs.be/emc.asp?pageId=616
http://www.cancerhelp.org.uk

More articles from Health and Medicine:

nachricht Purdue cancer identity technology makes it easier to find a tumor's 'address'
16.11.2018 | Purdue University

nachricht Microgel powder fights infection and helps wounds heal
14.11.2018 | Michigan Technological University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: UNH scientists help provide first-ever views of elusive energy explosion

Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.

Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

Purdue cancer identity technology makes it easier to find a tumor's 'address'

16.11.2018 | Health and Medicine

Good preparation is half the digestion

16.11.2018 | Life Sciences

Microscope measures muscle weakness

16.11.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>